	Basal ganglia neurophysiological markers of non-motor symptoms in Parkinson's disease: A systematic review. J Parkinsons Dis Keulen BJ, Beudel M, Malekzadeh A, de Bie RM, Swinnen BE. PMID: 42334335 [PubMed - as supplied by publisher]
	Mapping the Parkinson's pandemic: Unveiling and addressing the global burden. J Parkinsons Dis Shalash A, Schumacher-Schuh AF, Salama M, Noyce A, Ha ULN, Chew Seng Tan L, Tanner CM. PMID: 42334224 [PubMed - as supplied by publisher]
	Physical activity and exercise participation-Impact on motor and non-motor outcomes in early-stage Parkinson disease: A cross-sectional study. PM R Thrue C, Bonde-Jensen F, Hvid LG, Dalgas U, Langeskov-Christensen M. PMID: 42332367 [PubMed - as supplied by publisher]
	Iranian Deep Brain Stimulation Registry for Parkinson's Disease (IDBSR-PD): establishment and feasibility study. Acta Neurol Belg Abdollahifard S, Maghsoodzadeh S, Rezaei R, Najibi A, Heidarian A, Haghighi MM, Khademi F, Sabet S, Torabzade-Tari S, Karimi A, Razmkon A, Jaafari N. PMID: 42332325 [PubMed - as supplied by publisher]
	Expression of Concern: Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial. Lancet The Editors Of The Lancet. PMID: 42330995 [PubMed - as supplied by publisher]
	Efficacy of the voice-activated intelligent personal assistant (VIPA) intervention on psychosocial well-being among people with Parkinson's disease: A pilot randomized controlled trial. Parkinsonism Relat Disord Lau TK, Leung AYM. PMID: 42330833 [PubMed - as supplied by publisher]
	Association between CHRNA5 polymorphisms and Parkinson's disease in Northern Chinese Han population: a case-control study. Ann Hum Biol Xian W, Sun X, Wang Y, Sun X, Zhang J, Qin K, Zhou Y, He Q, Li Y, Xie A, Hou B. PMID: 42329050 [PubMed - indexed for MEDLINE]
	Glucagon-like peptide-1 receptor agonists in movement disorders: From Parkinson's disease to the broader spectrum - Mechanisms, evidence, and future directions. Clin Park Relat Disord Dahshan A, Khalil MIM, El-Jaafary SI, Al Yamani A. PMID: 42328044 [PubMed]
	Bipolar disorder and subsequent Parkinson's disease: a meta-analysis of cohort studies. Front Neurol Su L, Feng X, Chen Y, Tang Z, Shi W, Qiu Y, Ma X. PMID: 42327803 [PubMed]
	Evidence for exponential progression in advanced Parkinson's disease: retrospective analysis of a prospective cohort study. Front Neurol Yener SM, Ding C, Ganesvaran G, Alty JE, Clissold BG, McColl CD, Reardon KA, Schiff M, Kempster PA. PMID: 42327801 [PubMed]
	Vascular Phenotyping in Parkinson's Disease: Diabetes Mellitus Operationalizes a Microvascular Metabolic Syndrome Cluster Across PPMI Diagnostic Cohorts. medRxiv Belnavis A, Chiu SY, Chen K, Thorpe RJ, Ofori E, Parkinson Precision Medicine Initiative. PMID: 42326795 [PubMed]
	Analyzing Gait Pattern Associated With Neuropsychiatric Symptoms in Parkinson's Disease by a Comprehensive Approach. IEEE J Transl Eng Health Med Russo M, Ricciardi C, Mestizia M, Filippo FD, Pisani N, de Biasi G, Ponsiglione AM, Barone P, Amboni M, Romano M. PMID: 42325440 [PubMed - indexed for MEDLINE]
	Art-based interventions and non-motor outcomes in Parkinson's disease: a systematic review and meta-analysis. Front Psychol Liu Z, An S, Liu S, Wang Q, Jiang B. PMID: 42325316 [PubMed]
	The impact of arts-based interventions on alleviating motor and non-motor symptoms in Parkinson's disease: A meta-analysis and systematic review. Geriatr Nurs Liu Z, Liu S, Hui C, Wang R, Ye W. PMID: 42323228 [PubMed - as supplied by publisher]
	Progressive orexin A positive neuron loss in the 6-OHDA mouse model of Parkinson's disease: a pilot study with validation of an orexin A immunohistochemistry protocol for paraffin-embedded tissue. Brain Res Braun A, Vo PT, Bobrovskaya L. PMID: 42323123 [PubMed - as supplied by publisher]
	Corrigendum to "Large-scale profiling of blood microbial signatures in patients with Parkinson's disease and its association with disease progression: a cross-sectional study" [EBioMedicine 126(2026) 106224]. EBioMedicine Jian X, Yu P, Zhang Y, Pan H, Wu K, Zhang H, Zhang H, Huang Y, Zhao Y, Wang Y, Wang Y, Zhou Q, Zhang X, Zhao G, Li B, Guo J, Xia K, Tang B, Li J. PMID: 42322852 [PubMed - as supplied by publisher]
	Identification of natural MAO-B inhibitors with enhanced binding and dynamic stability: Implications for Parkinson's disease therapy. Comput Biol Chem Sayadi M, Ramazani A, Zarei A. PMID: 42322787 [PubMed - as supplied by publisher]
	An exploratory (18)F-Florzolotau tau PET study in putative body-first versus brain-first Parkinson's disease. Eur J Nucl Med Mol Imaging Xu C, Jiao F, Ni Y, Xu Z, Hu T, Li S, Li X, Liang X, Wang J, Zuo C, Tang Y. PMID: 42322399 [PubMed - as supplied by publisher]
	Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: The ORCHESTRA Study. Neurol Ther Warnecke T, Van der Plas AA, Schwingenschuh P, Johansson A, Simu M, O'Meara M, Gupta R, Fritz B, Bergmann L, Parra JC, Südmeyer M. PMID: 42322391 [PubMed - as supplied by publisher]
	The role of dynamic Lowenstein occupational therapy and cognitive assessment scale for the elderly with Parkinson's disease. BMC Geriatr Yaman F, Ar, Soylu EA, Pek, Leblebicier MA, Özlü A, Gökp, Yenen B, Kavuncu V. PMID: 42321630 [PubMed - as supplied by publisher]

Articles 1 - 20 / 57868

Page 1 of 2894



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy